Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?
Authors
Keywords
-
Journal
EYE
Volume 27, Issue 1, Pages 56-64
Publisher
Springer Nature
Online
2012-11-23
DOI
10.1038/eye.2012.225
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
- (2012) Daniel F. Martin et al. OPHTHALMOLOGY
- Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
- (2012) Usha Chakravarthy et al. OPHTHALMOLOGY
- Outcome of ranibizumab treatment in neovascular age related macula degeneration in eyes with baseline visual acuity better than 6/12
- (2011) T A Williams et al. EYE
- Myositis Ossificans
- (2011) Deborah A. Martin et al. NEW ENGLAND JOURNAL OF MEDICINE
- ONE-YEAR RESULTS OF A FLEXIBLE REGIMEN WITH RANIBIZUMAB THERAPY IN MACULAR DEGENERATION
- (2011) Luis Arias et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Effectiveness of ranibizumab for neovascular age-related macular degeneration using clinician-determined retreatment strategy
- (2010) A. Kumar et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Effectiveness of intravitreal ranibizumab for the treatment of neovascular age-related macular degeneration in a Canadian retina practice: a retrospective review
- (2010) Taha Bandukwala et al. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE
- A Treat and Extend Regimen Using Ranibizumab for Neovascular Age-Related Macular DegenerationClinical and Economic Impact
- (2010) Omesh P. Gupta et al. OPHTHALMOLOGY
- INJECT AND EXTEND DOSING VERSUS DOSING AS NEEDED
- (2010) Hassiba Oubraham et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Effects of Ranibizumab in Patients with Subfoveal Choroidal Neovascularization Attributable to Age-related Macular Degeneration
- (2009) Simon P. Rothenbuehler et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Results of One-Year's Treatment with Ranibizumab for Exudative Age-related Macular Degeneration in a Clinical Setting
- (2009) Salomon Y. Cohen et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Ranibizumab for exudative age-related macular degeneration: 24-month outcomes from a single-centre institutional setting
- (2009) G. Querques et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Ranibizumab treatment for neovascular age-related macular degeneration: from randomized trials to clinical practice
- (2009) K Michalova et al. EYE
- One-year results of intravitreal ranibizumab for neovascular age-related macular degeneration and clinical responses of various subgroups
- (2009) Seungbum Kang et al. JAPANESE JOURNAL OF OPHTHALMOLOGY
- Evaluation of Injection Frequency and Visual Acuity Outcomes for Ranibizumab Monotherapy in Exudative Age-related Macular Degeneration
- (2009) Hajir Dadgostar et al. OPHTHALMOLOGY
- Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
- (2008) David M. Brown et al. OPHTHALMOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search